For example, cancer-associated PKC mutants that impair PKC autoinhibition, including cancer fusion proteins, are paradoxically loss-of-function because mutant protein is degraded by this quality control pathway (Baffi et al., 2019; Van et al., 2021). This evidence concerns the gene PRRT2 and cancer.